Legal Storm Clouds Gather as Pfizer Faces Critical Court Decision

The pharmaceutical behemoth Pfizer confronts one of its most significant legal challenges in recent memory today. A Florida court is ...

Pfizer Bets Billions on Obesity Market Entry with Metsera Acquisition

by Robert Sasse

September 26, 2025

0

In a bold strategic pivot, pharmaceutical giant Pfizer is making a monumental move into the obesity drug market. The company ...

Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena

by Dieter Jaworski

September 22, 2025

0

In a move signaling its serious intent to capture a share of the lucrative anti-obesity drug market, US pharmaceutical titan ...

Pfizer’s Strategic Pivot: Seeking External Partner for Promising Cancer Drug

by Felix Baarz

September 18, 2025

0

In a notable strategic shift, Pfizer and its collaborator Arvinas have announced they will seek an external commercialization partner for ...

Navigating Political Headwinds and Pipeline Setbacks: Pfizer’s Strategic Pivot

by Andreas Sommer

September 17, 2025

0

Pfizer finds itself navigating increasingly turbulent political waters as it works to reduce its reliance on COVID-related products. Simultaneous regulatory ...

Pfizer’s Vaccine Breakthrough: A Turning Point for the Struggling Stock?

by Felix Baarz

September 8, 2025

0

Pharmaceutical giants Pfizer and BioNTech have announced positive clinical trial results for their updated COVID-19 vaccine, timed to coincide with ...

Pfizer’s Narrow Vaccine Approval Presents Commercial Challenge

by Felix Baarz

September 2, 2025

0

Pfizer has secured a critical regulatory milestone, receiving FDA approval for its updated COVID-19 vaccine, COMIRNATY LP.8.1. However, the triumph ...